tranylcypromine has been researched along with Central Nervous System Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almeida, AJ; Duarte, D; Gonçalves, LM; Marto, J; Silva, S; Soares, OSGP; Vale, N; Vasques-Nóvoa, F | 1 |
| HIRSCHMANN, J; MAYER, K | 1 |
| Corkeron, MA | 1 |
| Gillman, PK | 1 |
4 other study(ies) available for tranylcypromine and Central Nervous System Diseases
| Article | Year |
|---|---|
New Peptide Functionalized Nanostructured Lipid Carriers with CNS Drugs and Evaluation Anti-proliferative Activity.
Topics: Caco-2 Cells; Cell-Penetrating Peptides; Central Nervous System Diseases; Drug Carriers; Humans; Lipids; Nanoparticles; Nanostructures; Particle Size; Tranylcypromine | 2022 |
[NEW MEANS OF CONTROLLING EXTRAPYRAMIDAL MOTOR DISORDERS].
Topics: Central Nervous System Diseases; Dihydroxyphenylalanine; Drug Therapy; Electroencephalography; Extrapyramidal Tracts; Humans; Movement Disorders; Parkinsonian Disorders; Tranylcypromine | 1964 |
Serotonin syndrome--a potentially fatal complication of antidepressant therapy.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Central Nervous System Diseases; Humans; Male; Selective Serotonin Reuptake Inhibitors; Sertraline; Tranylcypromine | 1995 |
Successful treatment of serotonin syndrome with chlorpromazine.
Topics: Central Nervous System Diseases; Chlorpromazine; Clomipramine; Depression; Drug Interactions; Humans; Monoamine Oxidase Inhibitors; Selective Serotonin Reuptake Inhibitors; Syndrome; Tranylcypromine | 1996 |